KL and Alzheimer disease: In an animal model (APP/PS1) of AD, α-Klotho overexpression significantly decreased the percentage of Aβ plaques in the cortex and hippocampus and soluble Aβ1-40 and Aβ1-42, and also decreased NLRP3/caspase-1 inflammasome signaling [108].